InsiderTrades

Form 4/A for PBH Prestige Consumer Healthcare Inc.

Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-19 · accession 0001104659-23-064065 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMA 2023-05-24 2023-05-19 PBH Mekhail Adel EVP, Marketing, Sales M - OptEx $30.19 +17.2K 25.9K +198% +$519.1K
DMA 2023-05-24 2023-05-19 PBH Mekhail Adel EVP, Marketing, Sales S - Sale+OE $60.27 -17.2K 18.7K -48% -$1.04M
DMA 2023-05-24 2023-05-19 PBH Mekhail Adel EVP, Marketing, Sales M - OptEx $0.00 -17.2K 11.2K -61% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.01 per share 2023-05-19 M A 10,000 $30.19 28,681 D — —
2 Common Common Stock, par value $0.01 per share 2023-05-19 S D 10,000 $60.00 18,681 D — —
3 Common Common Stock, par value $0.01 per share 2023-05-19 M A 7,194 $30.19 25,875 D — —
4 Common Common Stock, par value $0.01 per share 2023-05-19 S D 7,194 $60.65 18,681 D — — (F1) This amendment is being filed to accurately reflect the exercise price of the options granted on May 13, 2019, which exercise price was inadvertently reported incorrectly in the original Form 4 filed on May 22, 2023. The correct exercise price is $60.65.
5 Derivative Employee Stock Options (rights to buy) 2023-05-19 M D 7,194 $0.00 4,000 D $30.19 · — to 2029-05-13 7.20 Common Stock (F2) Options vested and became exercisable on the third anniversary of the grant date.
6 Derivative Employee Stock Options (rights to buy) 2023-05-19 M D 10,000 $0.00 11,194 D $30.19 · — to 2029-05-13 10,000 Common Stock (F2) Options vested and became exercisable on the third anniversary of the grant date.